Related Experiment Video
Updated: Jun 28, 2026
06:21
Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Pharmacogenomics: a tool for improving cancer chemotherapy
Mariano Monzó1, Alfons Navarro, Gerardo Ferrer
1Department of Human Anatomy and Embryology, Laboratory of Molecular Oncology, Institut d'Investigacions Biomèdiques August Pi I Sunyer, Facultad de Medicina, UB, Barcelona, Spain. mmonzo@ub.edu
Summary
Genetic variations called polymorphisms in drug-metabolizing enzymes and DNA repair proteins can impact anticancer drug efficacy. Detecting these single-nucleotide polymorphisms (SNPs) is key to personalized cancer treatment strategies.
Area of Science:
- Pharmacogenomics
- Molecular Biology
- Oncology
Background:
- Anticancer drugs undergo metabolism and excretion within cells via Phase I/II enzymes and ABC-transporters.
- Genetic variations (polymorphisms) in these proteins can alter drug efficacy and toxicity.
- These polymorphisms are present in both normal and tumor cells, influencing treatment outcomes.
Purpose of the Study:
- To review the most effective methods for detecting single-nucleotide polymorphisms (SNPs).
- To describe key SNPs in enzymes involved in drug metabolism and DNA repair.
- To outline future research directions in pharmacogenomics for cancer therapy.
Main Methods:
- Review of literature on SNP detection methodologies.
- Identification and description of significant SNPs in drug-metabolizing and DNA repair enzymes.
- Discussion of emerging research trends in the field.
Main Results:
- Single-nucleotide polymorphism (SNP) detection methods are crucial for understanding drug response.
- Specific SNPs in Phase I/II enzymes and ABC-transporters significantly impact anticancer drug metabolism and efficacy.
- Polymorphisms in DNA repair enzymes also play a role in treatment effectiveness.
Conclusions:
- SNP detection is vital for predicting and optimizing anticancer drug therapy.
- Understanding genetic variations in drug metabolism and DNA repair pathways enables personalized medicine approaches.
- Future research should focus on novel SNP detection techniques and their clinical application in oncology.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...